Přejít k hlavnímu obsahu

Journals 2023

GIACCHERINI, M., L. GORI, M. GENTILUOMO, R. FARINELLA, K. CERVENA, J. SKIECEVICIENE, F. DIJK, G. CAPURSO, A. VEZAKIS, L. ARCHIBUGI, R. CHAMAS, T. HUSSEIN, F. TAVANO, P. HEGYI, M. LOVEČEK, J. IZBICKY, H. BRENNER, B. MOHELNÍKOVÁ DUCHOŇOVÁ, G. DELL´ANNA, J. KUPCINSKAS, S. ERMINI, M. NOBREGA AOKI, J. NEOPTOLEMOS, M. GAZOULI, C. PASQUALI, R. PEZZILLLI, R. TALAR-WOJNAROWSKA, M. OLIVERIUS, M. AL-SAEEDI, M. LUCCHESI, N. FURBETTA, S. CARRARA, C. VAN EIJCK, A. MALECKAS, A. MILANETTO, R. LAWLOR, B. SCHOTTKER, U. BOGGI, L. MORELLI, L. GINOCCHI, R. PONZ DE LEON, C. SPERTI, A. ZERBI, L. ARCIDIACONO, F. UZUNOGLU, B. HOLLECZEK, D. GIOFFREDA, E. MALECKA-WOJCIESKO, M. KIUDELIS, A. SZENTESI, H. VAN LAARHOVEN, P. SOUCEK, M. GOTZ, B. EROSS, G. CAVESTRO, D. BASSO, F. PERRI, S. LANDI, F. CANZIAN, D. CAMPA
A scan of all coding region variants of the human genome, identifies 13q12.2-rs9579139 and 15q24.1-rs2277598 as novel risk loci for pancreatic ductal adenocarcinoma. Carcinogenesis. 2023, ISSN: 0143-3334, PMID: 37670727,
VECERA, L., P. PRASIL, J. SROVNAL, E. BERTA, M. VIDLAŘOVÁ, T. GABRHELIK, P. KOUŘILOVÁ, M. LOVEČEK, P. SKALICKÝ, J. ŠKARDA, Z. KALA, P. MICHALEK, M. HAJDÚCH
Morphine Analgesia, Cannabinoid Receptor 2, and Opioid Growth Factor Receptor Cancer Tissue Expression Improve Survival after Pancreatic Cancer Surgery. Cancers. 2023, 15(16), 4038, ISSN: 2072-6694, PMID: 37627066,  PDF.
LEMBERG, K., E. ALI, M. KRECMEROVA, J. AGULIAR, J. ALT, D. PETERS, L. ZHAO, Y. WU, N. NUHA, J. ASARA, V. STAEDTKE, C. PRATILAS, P. MAJER, R. RAIS, I. BEN-SAHRA
Pro-905, a Novel Purine Antimetabolite, Combines with Glutamine Amidotransferase Inhibition to Suppress Growth of Malignant Peripheral Nerve Sheath Tumor. Molecular Cancer Therapeutics. 2023, 22(12), 1390-1403, ISSN: 1535-7163, PMID: 37616542,
KAPLANEK, R., Z. KEJIK, J. HAJDUCH, K. VESELA, K. KUCNIROVA, M. SKALICKOVA, A. VENHAUEROVA, B. HOSNEDLOVA, R. HROMADKA, P. DYTRYCH, P. NOVOTNY, N. ABRAMENKO, V. ANTONYOVA, D. HOSKOVEC, P. BABULA, M. MASARIK, P. MARTASEK, M. JAKUBEK
TET protein inhibitors: Potential and limitations. Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie. 2023, 166, 115324, ISSN: 0753-3322, PMID: 37598475.
KAHOUNOVA, Z., M. PICKOVA, S. DRAPELA, J. BOUCHAL, E. SZCZYRBOVA, J. NAVRATIL, K. SOUCEK
Circulating tumor cell-derived preclinical models: current status and future perspectives. Cell Death & Disease. 2023, 14(8), 530, ISSN: 2041-4889, PMID: 37591867,
JESETA, M., A. POSPISILOVA, L. MEKINOVA, K. FRANZOVA, P. VENTRUBA, E. LOUSOVA, B. KEMPISTY, T. OŽDIAN, J. ZAKOVA, I. CRHA
Non-Invasive Diagnostics of Male Spermatogenesis from Seminal Plasma: Seminal Proteins. Diagnostics (Basel, Switzerland). 2023, 13(15), 2468, ISSN: 2075-4418, PMID: 37568830,  PDF.
CHEN, G., H. WANG, L. BUMBA, J. MASIN, P. SEBO, L. HONGBIN
The adenylate cyclase toxin RTX domain follows a series templated folding mechanism with implications for toxin activity. The Journal of Biological Chemistry. 2023, 299(9), 105150, ISSN: 0021-9258, PMID: 37567473,
Nucleoside-based anticancer drugs: mechanism of action and drug resistance. Biochemical Pharmacology. 2023, ISSN: 0006-2952 , PMID: 37567317,  PDF.
PETERS, D., L. NORRIS, L. TENORA, I. SNAJDR, A. PONTI, X. ZHU, S. SAKAMOTO, V. VEERVALLI, M. PRADHAN, J. ALT, A. THOMAS, P. MAJER, R. RAIS, C. MCDONALD, B. SLUSHER
A gut-restricted glutamate carboxypeptidase II inhibitor reduces monocytic inflammation and improves preclinical colitis. Science Translational Medicine. 2023, 15(708), eabn7491, ISSN: 1946-6234, PMID: 37556558,
WAZYNSKA, M., R. BUTERA, M. REQUESENS, A. PLAT, T. ZARGANES-TZITZIKAS, C. NEOCHORITIS, J. PLEWKA, L. SKALNIAK, J. KOCIK-KROL, B. MUSIELAK, K. MAGIERA-MULARZ, I. RODRIGUEZ, S. BLOK, M. DE BRYUN, H. NIJMAN, P. ELSINGA, T. HOLAK, A. DÖMLING
Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors. Journal of Medicinal Chemistry. 2023, 66(14), 9577-9591, ISSN: 0022-2623, PMID: 37450644,